Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 2, 2017, by Cellectis S.A., a foreign private issuer based in Paris, France, incorporates by reference the company's interim report for the quarter and six-month period ended June 30, 2017 (Exhibit 99.1). The filing serves to update U.S. investors on the company's status during this interim period.
Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt. The filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text, as the document serves only to reference the attached interim report.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the referenced Exhibit 99.1, which is not included in the input content.
Key Facts for Investor Verification
- Verify the full content of Exhibit 99.1 (Interim Report for the quarter and six months ended June 30, 2017) for actual financial performance data.
- Confirm the company's filing status as a registrant under Form 20-F.
- Note that this Form 6-K is incorporated by reference into the registration statement on Form F-3 (No. 333-217086).
- Identify André Choulika as the Chief Executive Officer who authorized the filing.